Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.
about
Structural basis for chemical inhibition of human blood coagulation factor XaBlood coagulation, inflammation, and malaria.Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascadesLung fibrosis.Acquired antithrombin deficiency in sepsis.Protein C replacement in severe meningococcemia: rationale and clinical experience.Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.A fibrin based model for rheumatoid synovitis.Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivoHypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling.Potential effector and immunoregulatory functions of mast cells in mucosal immunity.Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.Innate immunity, coagulation and placenta-related adverse pregnancy outcomes.Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases.Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects.Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.Does the intensity of the inflammatory reaction in a bruise depend on its proximity to the site of trauma?Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice.Oral factor Xa inhibitors for the long-term management of ACS.Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.Inflammatory, hemostatic, and clinical changes in a baboon experimental model for heatstroke.Role of p38 mitogen-activated protein kinase in thrombus formation.Effects of rivaroxaban on intimal hyperplasia and smooth muscle cell proliferation at the carotid artery anastomosis site in rabbits.iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats.Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.Audiometric characteristics in patients with noise-induced hearing loss after sodium enoxaparin treatment.Blockade of tissue factor: treatment for organ injury in established sepsis.Nanoparticles Can Wrap Epithelial Cell Membranes and Relocate Them Across the Epithelial Cell Layer
P2860
Q27758367-60793E45-A98B-42F3-ACE5-74A3F8926259Q33378580-E95F6EF3-8D37-4435-85E2-FAEA5FA16BF9Q33750461-914F1FA0-CC9F-4E53-B4C4-02BFE8CB5935Q33756657-7D735CE6-8B36-4646-97FB-6B6EF14BC6E2Q33922885-943297E5-4520-4C99-B345-C2CCBE4C9D0FQ34005621-02069469-24BA-44F6-B4EB-DEE0D5FADDF8Q34135317-3DFC8872-B972-4699-8909-83C679D91862Q34219618-E7D40C15-C8A1-4993-A777-41A778644398Q34579752-F2C82B8F-074B-4329-B1EE-28A9257A8D7AQ35099133-C98A865F-1A57-4F86-BD58-37615F0C23DBQ35596311-C3177B15-77C4-450F-B445-DCA2059795CAQ35786887-6D085DA6-A0F2-47F0-AFA7-CFC1B9C8F821Q36170226-352EEB11-1EA6-43D8-AE12-6C0E19773805Q36480208-FFBBF543-4543-42AE-9345-9D76CF20CCA6Q36539857-9EE4C9A6-6172-4BDE-A126-6C4D155340A3Q37390247-294949D7-E261-4BA1-9947-ED46FE42F72FQ37457072-AB09A372-2748-4BF0-81C2-1746F0CC4C9EQ39031297-E4A40A7E-227E-4416-AB58-CD8629FF4952Q39752330-140EDA6D-CE24-499B-8F5D-56A6418162D5Q39799622-CC8E35CE-0E99-478B-BB20-D051083FDF5FQ40123143-80E270F0-CD2E-4911-8F24-70DA297A9F8EQ42750303-81AE5D39-772C-4C57-AA67-5F40F26D5AF1Q43594298-95FD0571-C9BA-40B5-BDB6-FECE52C844F6Q44009213-FE786577-7550-4EFC-AF80-A4A05957C098Q45099514-5FB94AEC-FC36-45EE-AB6C-26E9A49C6229Q45222435-C9691239-268A-49A7-B602-BEF015DBBDC9Q47154573-D04CB483-94E0-44BE-B645-5F4CFA277317Q47339402-C2D72CA3-0373-475F-8D00-0D3B6088B43BQ47745886-FEF041A2-4B2A-4523-8E97-E02BB960C3D9Q48625308-ECB84107-9160-4718-9FD0-FC8558EB7A5CQ51676119-E465CC73-5DBB-410F-A246-D0036C9C150DQ58833824-99A5C227-B591-4CFA-83B1-B822CB986B80
P2860
Factor Xa as an interface between coagulation and inflammation. Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@en
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@nl
type
label
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@en
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@nl
prefLabel
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@en
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@nl
P2093
P2860
P356
P1476
Factor Xa as an interface betw ...... es acute inflammation in vivo.
@en
P2093
D C Altieri
G Ambrosini
G DeDominicis
L Sorrentino
P2860
P304
P356
10.1172/JCI119428
P407
P577
1997-05-01T00:00:00Z